News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
666,302 Results
Type
Article (48230)
Company Profile (154)
Press Release (617918)
Multimedia
Podcasts (61)
Webinars (9)
Section
Business (184723)
Career Advice (2816)
Deals (33858)
Drug Delivery (99)
Drug Development (75550)
Employer Resources (164)
FDA (16517)
Job Trends (15358)
News (319397)
Policy (31791)
Tag
2024 BioCapital Digital (1)
2024 BioForest Digital (3)
2024 BioForest Standard (1)
2024 BioMidwest Digital (4)
2024 BioMidwest Standard (1)
2024 Bio NC Digital (4)
2024 Bio NC Standard (1)
2024 Biotech Bay Standard (16)
2024 Biotech Beach Digital (7)
2024 Biotech Beach Standard (4)
2024 Genetown Standard (9)
2024 Lone Star Bio Digital (1)
2024 Pharm Country Digital (3)
2024 Pharm Country Standard (5)
2025 Lone Star Bio Digital (4)
2026 BioCapital Elite (1)
2026 BioCapital Standard (1)
2026 BioMidwest Elite (2)
2026 Bio NC Standard (1)
2026 Biotech Bay Elite (1)
2026 Biotech Bay Standard (1)
2026 Biotech Beach Elite (2)
2026 Genetown Elite (3)
2026 Genetown Standard (1)
2026 Pharm Country Elite (1)
2026 Pharm Country Premier (1)
2026 Pharm Country Standard (2)
Academia (2811)
Academic (1)
Accelerated approval (5)
Adcomms (25)
Allergies (89)
Alliances (46211)
ALS (95)
Alzheimer's disease (1444)
Antibody-drug conjugate (ADC) (113)
Approvals (16524)
Artificial intelligence (262)
Autoimmune disease (27)
Automation (15)
Bankruptcy (321)
Best Places to Work (12292)
BIOSECURE Act (17)
Biosimilars (101)
Biotechnology (105)
Bladder cancer (66)
Brain cancer (25)
Breast cancer (276)
Cancer (2169)
Cardiovascular disease (181)
Career advice (2344)
Career pathing (32)
CAR-T (150)
Cell therapy (426)
Cervical cancer (20)
Clinical research (61418)
Collaboration (830)
Compensation (522)
Complete response letters (21)
COVID-19 (2637)
CRISPR (40)
C-suite (247)
Cystic fibrosis (104)
Data (2136)
Decentralized trials (2)
Denatured (22)
Depression (42)
Diabetes (271)
Diagnostics (6699)
Digital health (18)
Diversity (6)
Diversity, equity & inclusion (38)
Drug discovery (121)
Drug pricing (98)
Drug shortages (27)
Duchenne muscular dystrophy (93)
Earnings (72230)
Editorial (41)
Employer branding (21)
Employer resources (144)
Events (106909)
Executive appointments (740)
FDA (17773)
Featured Employer (61)
Fibrodysplasia Ossificans Progressiva (1)
Friedreich's ataxia (4)
Frontotemporal dementia (8)
Funding (750)
Gene editing (105)
Generative AI (23)
Gene therapy (303)
GLP-1 (704)
Government (4511)
Grass and pollen (5)
Guidances (49)
Healthcare (20337)
Huntington's disease (22)
IgA nephropathy (23)
Immunology and inflammation (111)
Indications (29)
Infectious disease (2781)
Inflammatory bowel disease (142)
Inflation Reduction Act (9)
Influenza (53)
Intellectual property (97)
Interviews (545)
IPO (16455)
IRA (34)
Job creations (3505)
Job search strategy (1950)
Kidney cancer (11)
Labor market (26)
Layoffs (454)
Leadership (22)
Legal (7259)
Liver cancer (69)
Lung cancer (302)
Lymphoma (139)
Machine learning (5)
Management (62)
Manufacturing (291)
MASH (69)
Medical device (14392)
Medtech (14397)
Mergers & acquisitions (18004)
Metabolic disorders (673)
Multiple sclerosis (77)
NASH (15)
Neurodegenerative disease (96)
Neuropsychiatric disorders (26)
Neuroscience (1980)
NextGen: Class of 2025 (6998)
Non-profit (4920)
Northern California (2630)
Now hiring (31)
Obesity (347)
Opinion (237)
Ovarian cancer (74)
Pain (90)
Pancreatic cancer (80)
Parkinson's disease (155)
Partnered (20)
Patents (229)
Patient recruitment (107)
Peanut (49)
People (55451)
Pharmaceutical (39)
Pharmacy benefit managers (21)
Phase I (19020)
Phase II (27123)
Phase III (20527)
Pipeline (1133)
Policy (129)
Postmarket research (2276)
Preclinical (7890)
Press Release (65)
Prostate cancer (99)
Psychedelics (32)
Radiopharmaceuticals (260)
Rare diseases (391)
Real estate (5491)
Recruiting (66)
Regulatory (22133)
Reports (26)
Research institute (2542)
Resumes & cover letters (453)
Rett syndrome (4)
RNA editing (3)
RSV (44)
Schizophrenia (72)
Series A (124)
Series B (83)
Service/supplier (8)
Sickle cell disease (57)
Southern California (2273)
Special edition (12)
Spinal muscular atrophy (150)
Sponsored (28)
Startups (3440)
State (2)
Stomach cancer (11)
Supply chain (68)
Tariffs (28)
The Weekly (38)
United States (23098)
Vaccines (685)
Venture capitalists (33)
Weight loss (226)
Women's health (31)
Worklife (17)
Date
Today (164)
Last 7 days (575)
Last 30 days (2575)
Last 365 days (33948)
2025 (10194)
2024 (36468)
2023 (41726)
2022 (52981)
2021 (57763)
2020 (56563)
2019 (49845)
2018 (37635)
2017 (33360)
2016 (32242)
2015 (37466)
2014 (27569)
2013 (22523)
2012 (24263)
2011 (24956)
2010 (22572)
Location
Africa (844)
Alabama (57)
Alaska (7)
Arizona (186)
Arkansas (14)
Asia (39213)
Australia (6959)
California (5996)
Canada (1983)
China (513)
Colorado (267)
Connecticut (281)
Delaware (142)
Europe (89298)
Florida (895)
Georgia (215)
Idaho (61)
Illinois (547)
India (26)
Indiana (316)
Iowa (9)
Japan (156)
Kansas (104)
Kentucky (26)
Louisiana (11)
Maine (70)
Maryland (921)
Massachusetts (4595)
Michigan (238)
Minnesota (392)
Mississippi (2)
Missouri (89)
Montana (31)
Nebraska (25)
Nevada (62)
New Hampshire (67)
New Jersey (1721)
New Mexico (30)
New York (1720)
North Carolina (1019)
North Dakota (8)
Northern California (2630)
Ohio (208)
Oklahoma (14)
Oregon (37)
Pennsylvania (1350)
Puerto Rico (12)
Rhode Island (33)
South America (1178)
South Carolina (22)
South Dakota (1)
Southern California (2273)
Tennessee (103)
Texas (892)
Utah (185)
Virginia (148)
Washington D.C. (62)
Washington State (560)
West Virginia (3)
Wisconsin (59)
666,302 Results for "diamyd medical ab".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Policy
Diamyd Medical receives U.S. FDA Fast Track designation for Diamyd®
Diamyd Medical announced that the U.S. Food and Drug Administration has granted Fast Track designation for Diamyd® that is being investigated to improve glycemic control in recently diagnosed stage 3 Type 1 Diabetes patients with the genotype HLA DR3-DQ2.
February 15, 2024
·
4 min read
Drug Development
Recruitment milestone reached in Diamyd® Phase 3 trial
Diamyd Medical’s precision medicine Phase 3 trial for Type 1 Diabetes, DIAGNODE-3, has enrolled 100 patients.
April 12, 2024
·
4 min read
Diamyd Medical announces a webcast presentation on October 20 regarding its industry partnership with JDRF
Diamyd Medical is hosting a webcast presentation on October 20th at 2:00 pm CET / 8:00 am EDT with Ulf Hannelius, CEO of Diamyd Medical, Josh Vieth, Director of Research at JDRF, as well as Mark Atkinson, Director for the University of Florida Diabetes Institute and member of the Board of Directors of Diamyd Medical.
October 17, 2023
·
2 min read
Press Releases
AB Science announces that EMA granted orphan drug status to AB8939 for the treatment of acute myeloid leukemia
April 23, 2025
·
7 min read
Press Releases
Arbutus to Present Imdusiran and AB-101 Data at EASL Congress 2025
April 23, 2025
·
7 min read
Press Releases
Notice to Annual General Meeting in AlzeCure Pharma AB
April 9, 2025
·
9 min read
Press Releases
BioInvent International AB Publishes Annual Report 2024
April 4, 2025
·
1 min read
Press Releases
Notice To Annual General Meeting of Spago Nanomedical AB (PUBL)
April 9, 2025
·
12 min read
Press Releases
Alligator Bioscience AB Reports Financial Results for Q1 2025 and Provides a Business Update
April 24, 2025
·
3 min read
Drug Development
Diamyd Medical partners with JDRF to advance the DIAGNODE-3 Phase 3 trial in Type 1 Diabetes
Diamyd Medical and JDRF, the leading global type 1 diabetes research and advocacy organization, have entered into a four-year research and development collaboration including a non-dilutive $5 million award to Diamyd Medical to support its ongoing Phase 3 trial with the precision medicine antigen-specific immunotherapy Diamyd®.
April 4, 2023
·
4 min read
1 of 66,631
Next
